Comprehensive Molecular Profiling of FLT3-Mutated Acute Myeloid Leukemia (AML) Patients Treated within the Ratify Trial (Alliance C10603)

被引：0

作者：

Jahn, Nikolaus ^{[1
]}

Panina, Ekaterina ^{[1
]}

Bullinger, Lars ^{[2
]}

Dolnik, Anna ^{[2
]}

Herzig, Julia ^{[1
]}

Blaette, Tamara J. ^{[2
]}

Benner, Axel ^{[3
]}

Krzykalla, Julia ^{[3
]}

Gathmann, Insa ^{[4
]}

Larson, Richard A. ^{[5
,6
]}

Lo-Coco, Francesco ^{[7
]}

Amadori, Sergio ^{[7
]}

Prior, Thomas W. ^{[8
]}

Brandwein, Joseph M. ^{[9
]}

Appelbaum, Frederick R. ^{[10
]}

Medeiros, Bruno C. ^{[11
]}

Tallman, Martin S. ^{[12
]}

Tiecke, Eva ^{[13
]}

Pallaud, Celine ^{[14
]}

Ehninger, Gerhard ^{[15
]}

Heuser, Michael ^{[16
]}

Ganser, Arnold ^{[16
]}

Stone, Richard M. ^{[17
]}

Thiede, Christian ^{[15
]}

Doehner, Hartmut ^{[1
]}

Bloomfield, Clara D. ^{[8
]}

Doehner, Konstanze ^{[1
]}

机构：

[1] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany

[2] Charite, Dept Hematol Oncol & Tumorimmunol, Berlin, Germany

[3] German Canc Res Ctr, Div Biostat, Heidelberg, Germany

[4] Novartis Pharma AG, Basel, Switzerland

[5] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA

[6] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA

[7] Univ Roma Tor Vergata, Rome, Italy

[8] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA

[9] Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON, Canada

[10] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA

[11] Stanford Univ, Ctr Canc, Stanford, CA 94305 USA

[12] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA

[13] Novartis Pharmaceut, Basel, Switzerland

[14] Novartis Pharmaceut, Oncol Precis Med, Novartis Oncol BU, Basel, Switzerland

[15] Univ Hosp Carl Gustav Carus, Internal Med 1, Dresden, Germany

[16] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany

[17] Dana Farber Partners CancerCare, Dept Med Oncol, Boston, MA USA

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-115842

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1534

引用

页数：6

共 50 条

[31] Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib [J].

Alexander E. Perl ;

Naoko Hosono ;

Pau Montesinos ;

Nikolai Podoltsev ;

Giovanni Martinelli ;

Nicki Panoskaltsis ;

Christian Recher ;

Catherine C. Smith ;

Mark J. Levis ;

Stephen Strickland ;

Christoph Röllig ;

Marco Groß-Langenhoff ;

Wen-Chien Chou ;

Je-Hwan Lee ;

Hisayuki Yokoyama ;

Nahla Hasabou ;

Qiaoyang Lu ;

Ramon V. Tiu ;

Jessica K. Altman .

Blood Cancer Journal, 12

[32] Gilteritinib activity in refractory or relapsed FLT3-mutated acute myeloid leukemia patients previously treated by intensive chemotherapy and midostaurin: a study from the French AML Intergroup ALFA/FILO [J].

Pierre-Yves Dumas ;

Emmanuel Raffoux ;

Emilie Bérard ;

Sarah Bertoli ;

Marie-Anne Hospital ;

Maël Heiblig ;

Yohann Desbrosses ;

Caroline Bonmati ;

Cécile Pautas ;

Juliette Lambert ;

Corentin Orvain ;

Anne Banos ;

Florence Pasquier ;

Pierre Peterlin ;

Tony Marchand ;

Madalina Uzunov ;

Jamilé Frayfer ;

Pascal Turlure ;

Thomas Cluzeau ;

Eric Jourdan ;

Chantal Himberlin ;

Emmanuelle Tavernier ;

Alban Villate ;

Stephanie Haiat ;

Marie-Lorraine Chretien ;

Martin Carre ;

Sylvain Chantepie ;

Ioana Vaida ;

Mathieu Wemeau ;

Safia Chebrek ;

Gaelle Guillerm ;

Romain Guièze ;

Houria Debarri ;

Eve Gehlkopf ;

Kamel Laribi ;

Ambroise Marcais ;

Alberto Santagostino ;

Marie-Christine Béné ;

Ariane Mineur ;

Arnaud Pigneux ;

Hervé Dombret ;

Christian Récher .

Leukemia, 2023, 37 :91-101

[33] Outcomes of FLT3-Mutated Acute Myeloid Leukemia Patients: A Single-Center, Real-World Experience [J].

Shoukier, Mahran ;

Kota, Vamsi ;

Jillella, Ravindra ;

Mian, Mohammad ;

Cortes, Jorge .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 :S313-S313

[34] Gilteritinib activity in refractory or relapsed FLT3-mutated acute myeloid leukemia patients previously treated by intensive chemotherapy and midostaurin: a study from the French AML Intergroup ALFA/FILO [J].

Dumas, Pierre-Yves ;

Raffoux, Emmanuel ;

Berard, Emilie ;

Bertoli, Sarah ;

Hospital, Marie-Anne ;

Heiblig, Mael ;

Desbrosses, Yohann ;

Bonmati, Caroline ;

Pautas, Cecile ;

Lambert, Juliette ;

Orvain, Corentin ;

Banos, Anne ;

Pasquier, Florence ;

Peterlin, Pierre ;

Marchand, Tony ;

Uzunov, Madalina ;

Frayfer, Jamile ;

Turlure, Pascal ;

Cluzeau, Thomas ;

Jourdan, Eric ;

Himberlin, Chantal ;

Tavernier, Emmanuelle ;

Villate, Alban ;

Haiat, Stephanie ;

Chretien, Marie-Lorraine ;

Carre, Martin ;

Chantepie, Sylvain ;

Vaida, Ioana ;

Wemeau, Mathieu ;

Chebrek, Safia ;

Guillerm, Gaelle ;

Guieze, Romain ;

Debarri, Houria ;

Gehlkopf, Eve ;

Laribi, Kamel ;

Marcais, Ambroise ;

Santagostino, Alberto ;

Bene, Marie-Christine ;

Mineur, Ariane ;

Pigneux, Arnaud ;

Dombret, Herve ;

Recher, Christian .

LEUKEMIA, 2023, 37 (01) :91-101

[35] Gilteritinib Activity in Refractory or Relapsed FLT3-Mutated Acute Myeloid Leukemia Patients Previously Treated By Intensive Chemotherapy and Midostaurin: A Study from the French AML Intergroup ALFA/Filo [J].

Dumas, Pierre-Yves ;

Raffoux, Emmanuel ;

Berard, Emilie ;

Bertoli, Sarah ;

Hospital, Marie Anne ;

Heiblig, Mael ;

Desbrosses, Yohan ;

Bonmati, Caroline ;

Pautas, Cecile ;

Lambert, Juliette ;

Orvain, Corentin ;

Banos, Anne ;

Pasquier, Florence ;

Peterlin, Pierre ;

Marchand, Tony ;

Uzunov, Madalina ;

Frayfer, Jamile ;

Turlure, Pascal ;

Cluzeau, Thomas ;

Jourdan, Eric ;

Himberlin, Chantal ;

Tavernier, Emmanuelle ;

Villate, Alban ;

Haiat, Stephanie ;

Chretien, Marie-Lorraine ;

Carre, Martin ;

Chantepie, Sylvain ;

Vaida, Iona ;

Wemeau, Mathieu ;

Chebrek, Safia ;

Guillerm, Gaelle ;

Guieze, Romain ;

Debarri, Houria ;

Gehlkopf, Eve ;

Laribi, Kamel ;

Marcais, Ambroise ;

Santagostino, Alberto ;

Bene, Marie C. ;

Mineur, Ariane C. ;

Pigneux, Arnaud ;

Dombret, Herve ;

Recher, Christian .

BLOOD, 2022, 140 :8996-8998

[36] An Analysis of Maintenance Therapy and Post-Midostaurin Outcomes in the International Prospective Randomized, Placebo-Controlled, Double-Blind Trial (CALGB 10603/RATIFY [Alliance]) for Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with FLT3 Mutations [J].

Larson, Richard A. ;

Mandrekar, Sumithra J. ;

Sanford, Ben L. ;

Laumann, Kristine ;

Geyer, Susan M. ;

Bloomfield, Clara D. ;

Thiede, Christian ;

Prior, Thomas W. ;

Dohner, Konstanze ;

Marcucci, Guido ;

Lo Coco, Francesco ;

Klisovic, Rebecca B. ;

Wei, Andrew ;

Sierra, Jorge ;

Sanz, Miguel A. ;

Brandwein, Joseph M. ;

de Witte, T. M. M. ;

Niederwieser, Dietger ;

Appelbaum, Frederick R. ;

Medeiros, Bruno C. ;

Tallman, Martin S. ;

Krauter, Jurgen ;

Schlenk, Richard F. ;

Ganser, Arnold ;

Serve, Hubert ;

Ehninger, Gerhard ;

Amadori, Sergio ;

Dohner, Hartmut ;

Stone, Richard M. .

BLOOD, 2017, 130

[37] Gilteritinib significantly prolongs overall survival in patients with FLT3-mutated (FLT3mut+) relapsed/refractory (R/R) acute myeloid leukemia (AML): Results from the Phase III ADMIRAL trial [J].

Perl, Alexander E. ;

Martinelli, Giovanni ;

Cortes, Jorge E. ;

Neubauer, Andreas ;

Berman, Ellin ;

Paolini, Stefania ;

Montesinos, Pau ;

Baer, Maria R. ;

Larson, Richard A. ;

Ustun, Celalettin ;

Fabbiano, Francesco ;

Di Stasi, Antonio ;

Stuart, Robert ;

Olin, Rebecca ;

Kasner, Margaret ;

Ciceri, Fabio ;

Chou, Wen-Chien ;

Podoltsev, Nikolai ;

Recher, Christian ;

Yokoyama, Hisayuki ;

Hosono, Naoko ;

Yoon, Sung-Soo ;

Lee, Je-Hwan ;

Pardee, Timothy ;

Fathi, Amir T. ;

Liu, Chaofeng ;

Liu, Xuan ;

Bahceci, Erkut ;

Levis, Mark J. .

CANCER RESEARCH, 2019, 79 (13)

[38] Salvage Treatment With Venetoclax (Ven) and Hypomethylating Agents (HMA) for Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia (AML) Patients: Clinical Characteristics and Outcomes [J].

Ghorab, Ahmad ;

Litzow, Mark ;

Gangat, Naseema ;

Al-Kali, Aref ;

Shah, Mithun ;

Murthy, Hemant ;

Alkhateeb, Hasan ;

Begna, Kebede ;

Patnaik, Mrinal ;

Foran, James ;

Badar, Talha .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 :S306-S306

[39] Tolerability and Efficacy of Crenolanib and Cytarabine/Anthracycline Chemotherapy in Older Patients (Aged 61 to 75) with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML) [J].

Wang, Eunice S. ;

Griffiths, Elizabeth A. ;

Walter, Roland B. ;

Tallman, Martin S. ;

Goldberg, Aaron D. ;

Messahel, Boo ;

Stone, Richard M. .

BLOOD, 2019, 134

[40] Emerging Real-World Midostaurin Treatment Patterns and Outcomes in FLT3-Mutated Acute Myeloid Leukemia at a Comprehensive Cancer Center [J].

Willis, Connor ;

Menon, Jyothi ;

Unni, Sudhir ;

Au, Trang ;

Ndife, Briana ;

Joseph, George J. ;

Bonifacio, Gaetano J. ;

Stein, Eytan M. ;

Tantravahi, Srinivas K. ;

Shami, Paul J. ;

Kovacsovics, Tibor ;

Brixner, Diana ;

Stenehjem, David Dean .

BLOOD, 2018, 132

← 1 2 3 4 5 →